Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases

(2022) Hasnat Tariq et al.   Frontiers in Microbiology

Plant-Derived Cell-Free Biofactories for the Production of Secondary Metabolites

(2022) Matthias Buntru et al.   Frontiers in Plant Science

Cell-free technologies for biopharmaceutical research and production

(2022) James F Zawada et al.   CURRENT OPINION IN BIOTECHNOLOGY

Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure

(2022) V.V. Egorov et al.   BIOPHYSICAL CHEMISTRY

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

(2021) Saghi Nooraei et al.   JOURNAL OF NANOBIOTECHNOLOGY

Escherichia Coli-Based Cell-Free Protein Synthesis for Iterative Design of Tandem-Core Virus-Like Particles

(2021) Noelle Colant et al.   Vaccines

MCP-1: Function, regulation, and involvement in disease

(2021) Sanjiv Singh et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Synthesis and Assembly of Hepatitis B Virus-Like Particles in a Pichia pastoris Cell-Free System

(2020) Alex J. Spice et al.   Frontiers in Bioengineering and Biotechnology

In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process

(2020) Yao Zhang et al.   PROTEIN EXPRESSION AND PURIFICATION

Emerging Concepts and Technologies in Vaccine Development

(2020) Morgan Brisse et al.   Frontiers in Immunology

Application of Cell-Free Protein Synthesis for Faster Biocatalyst Development

(2019) Jascha Rolf et al.   Catalysts

Exploring the Potential of Cell-Free Protein Synthesis for Extending the Abilities of Biological Systems

(2019) Khushal Khambhati et al.   Frontiers in Bioengineering and Biotechnology

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide

(2018) Jens Schumacher et al.   JOURNAL OF NANOBIOTECHNOLOGY

New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue

(2018) Karl D. Brune et al.   Frontiers in Immunology

Virus-like particle vaccines: immunology and formulation for clinical translation

(2018) Braeden Donaldson et al.   Expert Review of Vaccines

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications

(2017) Izzat Fahimuddin Bin Mohamed Suffian et al.   Scientific Reports

A versatile coupled cell-free transcription-translation system based on tobacco BY-2 cell lysates

(2015) Matthias Buntru et al.   BIOTECHNOLOGY AND BIOENGINEERING

Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems

(2015) Anne Zemella et al.   CHEMBIOCHEM

Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery

(2015) Yuan Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency

(2015) Nikolai V. Ravin et al.   VACCINE

Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins

(2015) Hadrien Peyret et al.   PLoS One

Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system

(2014) Matthias Buntru et al.   BMC BIOTECHNOLOGY

The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells

(2014) Joke M.M. den Haan et al.   IMMUNOLOGY LETTERS

Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2

(2014) Teizo Yoshimura et al.   Frontiers in Immunology

Hepatitis B core–based virus–like particles to present heterologous epitopes

(2013) Kenny Roose et al.   Expert Review of Vaccines

Epitope-distal Effects Accompany the Binding of Two Distinct Antibodies to Hepatitis B Virus Capsids

(2013) Jessica Z. Bereszczak et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

3.5Å cryoEM Structure of Hepatitis B Virus Core Assembled from Full-Length Core Protein

(2013) Xuekui Yu et al.   PLoS One

Antigenic Switching of Hepatitis B Virus by Alternative Dimerization of the Capsid Protein

(2012) Michael A. DiMattia et al.   STRUCTURE

SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure

(2011) Andreas Walker et al.   Scientific Reports

Robotic large-scale application of wheat cell-free translation to structural studies including membrane proteins

(2010) Emily T. Beebe et al.   New Biotechnology

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Enzymatic assembly of DNA molecules up to several hundred kilobases

(2009) Daniel G Gibson et al.   NATURE METHODS

Recombinant hepatitis B virus core particles: Association, dissociation and encapsidation of green fluorescent protein

(2008) Khai Wooi Lee et al.   JOURNAL OF VIROLOGICAL METHODS

Global trends in emerging infectious diseases

(2008) Kate E. Jones et al.   NATURE

High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers

(2008) Dace Skrastina et al.   VACCINE

Escherichia coli-based cell-free synthesis of virus-like particles

(2007) Bradley C. Bundy et al.   BIOTECHNOLOGY AND BIOENGINEERING